Head and Neck Squamous Cell Carcinoma
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (2) HC (2) | PD-L1 (CPS) >= 1 | Head and Neck Squamous Cell Carcinoma | Pembrolizumab |